FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Bayer sells subsidiary in €1.2B deal

Bayer has struck a deal to sell its material sciences division, H.C. Starck, to a group of investors for €1.2 billion. Bayer had announced earlier that it was shopping the subsidiary to help cover the cost of acquiring Schering. Germany's H.C. Starck, which makes specialty chemicals and metal and chemical powders, will be positioned for a public offering in three to five years.

- see the press release
- read the Pittsburgh Business Journal report

Related Articles:
Bayer Schering outlines global R&D restructuring. Report
Bayer outbids Merck KGaA for Schering. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about restructuring   Merck KgAA   public offering   Mergers and Acquisitions